- DarioHealth (NASDAQ:DRIO) announces that the FDA has granted 510(k) clearance for the Lightning-enabled version of the Dario Blood Glucose Monitoring System which enables the use of the Dario app on iPhone 7, 8 and X smart mobile devices.
- The launch of Apple's smartphones with only a Lightning connector posed a unique challenge to the entire mobile ecosystem. With market clearance, the company can now offer to U.S. patients its proprietary meter with either a 3.5mm headphone jack or Lightning connector.
- Shares are up 34% premarket.